ImageneBio, Inc. Proceeds from Common Stock Issued
ImageneBio, Inc. (IMA) reported Proceeds from Common Stock Issued of $37.42 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-03-06
- ImageneBio, Inc. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $0.00.
- ImageneBio, Inc. proceeds from issuance of common stock for the quarter ending 2023-09-30 was -$123.00K.
- ImageneBio, Inc. proceeds from issuance of common stock for fiscal 2023 was $37.42M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$123.00K derived: sum of 2 quarters · filed 2025-03-06 | $37.42M 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $37.42M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $37.54M 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |